Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-10-09
2007-10-09
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S184100, C424S185100, C424S190100, C424S234100, C530S300000, C530S350000
Reexamination Certificate
active
11472812
ABSTRACT:
The invention relates to recombinant polypeptides and peptides and particularly to the polypeptide containing in its polypeptidic chain the following amino acid sequence: the one extending from the extremity constituted by nucleotide at position (1) to the extremity constituted by nucleotide at position (194) represented in FIG.4aand FIG.4b. The polypeptides and peptides of the invention can be used for the diagnostic of tuberculosis, and can also be part of the active principle in the preparation of vaccine against tuberculosis.
REFERENCES:
patent: 4299916 (1981-11-01), Litman et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 5916558 (1999-06-01), Content et al.
patent: 6531138 (2003-03-01), Content et al.
patent: 7083797 (2006-08-01), Content et al.
patent: A 905 582 (1987-04-01), None
patent: 0 288 306 (1988-10-01), None
Andersen (1994),Infection and Immunity, vol. 62, No. 6, pp. 2536-2544.
Audibert et al. (1993),Immunology Today, vol. 14, No. 6, pp. 281-284.
Borremans et al.,Infection and Immunity, vol. 57, No. 10, Oct. 1989, pp. 3123-3130, American Society for Microbiology.
Bruyn et al.,Microbial Pathogenesis, vol. 2, 1987, pp. 351-366, Academic Press Inc. (London) Ltd.
Cohen et al.,Biological Abstracts, vol. 84, 1987, Abstract No. 56349, Philadelphia, US.
DeBruyn et al. (1989),J. of Gen. Microbiology, vol. 135, pp. 79-84.
DeWit et al. (1990),Nucleic Acids Research, vol. 18, No. 13, p. 3995.
Matsuo et al.,Journal of Bacteriology, vol. 170, No. 9, Sep. 1988, pp. 3847-3854, American Society for Microbiology.
Munk et al. (1988),Eur. J. of Immunol., vol. 18, pp. 1835-1838.
New England Biolabs Catalog (1986/87, New England Biolabs, Beverly, MA, USA), p. 60.
Tasaka et al.,Chemical Abstracts, vol. 99, No. 11, Sep. 12, 1983, p. 413, Abstract No. 86251m, Columbus Ohio, US.
Turner et al. (1988),J. of Clin. Microbiol., vol. 26, No. 9, pp. 1714-1719.
Wiker et al. (1990),Infection and Immunity, vol. 58, No. 1, pp. 272-274.
Wiker et al.,Int. Archs. Allergy Appl. Immun., vol. 81, 1986, pp. 307-314, S. Karger AG, Basel, DE.
Worsaag et al. (1987),Inf. and Immunity, vol. 55, No. 12, pp. 2922-2927.
Young et al. (1992),Molecular Microbiology, vol. 6, No. 2, pp. 133-145.
Young et al.,Proc. Natl. Acad. Sci. USA, vol. 82, May 1985, pp. 2583-2587.
Content Jean
De Bruyn Jacqueline
De Wit Lucas
Van Vooren Jean-Paul
N.V. Innogenetics S.A.
Swartz Rodney P
LandOfFree
32-kDa protein derived from Mycobacterium tuberculosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 32-kDa protein derived from Mycobacterium tuberculosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 32-kDa protein derived from Mycobacterium tuberculosis and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3876771